Biopharm Reports Releases New Findings on DNA and RNA Isolation Markets

The use of kit-based isolation methods is expected to grow by 16% in the next three years

Online PR News – 30-October-2013 – London – Methods used to isolate DNA and RNA are fundamental to most molecular biology studies. In the past, these were often complex, time-consuming, labour-intensive and limited in throughput. Today, many specialised methods are available, from conventional solution-based approaches to solid-phase systems often seen in commercial kits.

Given the growth of molecular biology over the last decade, it is not surprising that end-user nucleic acid isolation methods are developing rapidly. In a new global study by Biopharm Reports involving end-users in 50 countries, it was found that around two thirds of individuals currently use kit-based methods, compared to one third who use non-kit methods. However, looking at the anticipated use of kit and non-kit methods for DNA and RNA isolations three years from now, almost three quarters of end-users anticipate they will be using kit-based methods (an estimated increase of 16%) while around one quarter anticipated they will be using non-kit methods (an estimated fall of around 27%; 9% per year overall) during that time. The study also found increasing demand for automated isolation methods.

Biopharm Reports carries out country-wide and global market studies of techniques, methods, and instrumentation used in life science and clinical laboratories. These are conducted through specialist groups of experienced end-users and practitioners, and therefore findings are based on 'real world' market data.

Visit Our Site
Bookmarkse-mailGoogledel.icio.usStumbleUponSlashdotFurlDiggTechnoratiYahooMyWebBlinkListSpurlRawSugarWists
 
 
Contact Information
John Bates Ph.D
Biopharm Reports
Cambridgeshire, UK, PE28 3ND
+44 (0) 7599 841 895

Share and Connect